Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah M Bartsch

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Human Vaccines & Immunotherapeutics|April 24, 2014
Economics and financing of vaccines for diarrheal diseasesSarah M Bartsch, Bruce Y Lee
Plos Neglected Tropical Diseases|April 21, 2017
How to determine if a model is right for neglected tropical disease decision makingBruce Y Lee, Sarah M Bartsch
Pathogens and Global Health|January 13, 2015
The cost of an Ebola caseSarah M Bartsch, Katrin Gorham, Bruce Y Lee
Advances in Parasitology|March 14, 2015
Economic and financial evaluation of neglected tropical diseasesBruce Y Lee, Sarah M Bartsch, Katrin M Gorham
The Journal of Infectious Diseases|July 13, 2021
Corrigendum to: The Clinical and Economic Burden of Norovirus Gastroenteritis in the United StatesSarah M Bartsch, Kelly J O'Shea, Bruce Y Lee
Vaccine|October 23, 2012
The economic value of a quadrivalent versus trivalent influenza vaccineBruce Y Lee, Sarah M Bartsch, Alyssa M Willig
Infection Control and Hospital Epidemiology|May 9, 2013
Reply to Crnich and DrinkaBruce Y Lee, Sarah M Bartsch, Susan S Huang
The Journal of Infectious Diseases|July 17, 2020
The Clinical and Economic Burden of Norovirus Gastroenteritis in the United StatesSarah M Bartsch, Kelly J O'Shea, Bruce Y Lee
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2013
Is fidaxomicin worth the cost? An economic analysisSarah M Bartsch, Craig A Umscheid, Neil Fishman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2013
Reply to Simon, Shah et al, and Hartzema and ChenSarah M Bartsch, Craig A Umscheid, Neil Fishman, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Human Vaccines & Immunotherapeutics|April 24, 2014
Economics and financing of vaccines for diarrheal diseasesSarah M Bartsch, Bruce Y Lee
Plos Neglected Tropical Diseases|April 21, 2017
How to determine if a model is right for neglected tropical disease decision makingBruce Y Lee, Sarah M Bartsch
Pathogens and Global Health|January 13, 2015
The cost of an Ebola caseSarah M Bartsch, Katrin Gorham, Bruce Y Lee
Advances in Parasitology|March 14, 2015
Economic and financial evaluation of neglected tropical diseasesBruce Y Lee, Sarah M Bartsch, Katrin M Gorham
The Journal of Infectious Diseases|July 13, 2021
Corrigendum to: The Clinical and Economic Burden of Norovirus Gastroenteritis in the United StatesSarah M Bartsch, Kelly J O'Shea, Bruce Y Lee
Vaccine|October 23, 2012
The economic value of a quadrivalent versus trivalent influenza vaccineBruce Y Lee, Sarah M Bartsch, Alyssa M Willig
Infection Control and Hospital Epidemiology|May 9, 2013
Reply to Crnich and DrinkaBruce Y Lee, Sarah M Bartsch, Susan S Huang
The Journal of Infectious Diseases|July 17, 2020
The Clinical and Economic Burden of Norovirus Gastroenteritis in the United StatesSarah M Bartsch, Kelly J O'Shea, Bruce Y Lee
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2013
Is fidaxomicin worth the cost? An economic analysisSarah M Bartsch, Craig A Umscheid, Neil Fishman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2013
Reply to Simon, Shah et al, and Hartzema and ChenSarah M Bartsch, Craig A Umscheid, Neil Fishman, et al.
Pageof 10